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INTRODUCTION
Nitric oxide (NO) is an important modulator of vascular functions. Many of the effects of NO are mediated through the activation of cytosolic soluble guanylyl cyclase (sGC), an α and β subunit heterodimer. Upon NO binding to the sGC heme moiety, activity of sGC increases several hundred-fold over basal levels and activated sGC converts GTP to cGMP (17) , to initiate a cascade of multiple effector molecules, including protein kinases, phosphodiesterases and ion channels (9, 21) . Previous work has shown the existence of eNOS-hsp90-sGC complexes in both endothelial and smooth muscle cells; these complexes function to stabilize sGC and reduce inactivation of NO by superoxide forming peroxynitrite (25) . Inhibition of hsp90 by geldanamycin (GA) decreases of both α and β sGC protein levels and activity in rat smooth muscle cells, and this effect was blocked by the proteasome inhibitor N-benzoyloxycarbonyl (Z)-Leu-Leu-leucinal (MG132) (18), suggesting that the hsp90-based chaperone system is a regulator of sGC function.
Hsp90 is one of the most abundant proteins in eukaryotic cells (1-2% total protein); together with other chaperones and co-chaperones, it helps maintain quality control of cellular proteins. Recently CHIP (C terminus of hsp70 interacting protein) was identified as a protein quality control U-box-containing E3 ubiquitin ligase, which facilitates processing of chaperone client proteins. Through its three tandem tetratricopeptide repeats (TPR) domain, CHIP binds to the TPR acceptor sites on hsp90 and hsp70 proteins (3, 7) . CHIP has also been implicated in the ubiquitination and degradation of multiple chaperone client proteins, such as the glucocorticoid receptor (6), the cystic fibrosis transmembrane conductance regulator protein (15), and nNOS (19) . Additionally, CHIP interacts with eNOS by partitioning the soluble enzyme into the insoluble (inactive) cellular compartments that eventually leads to the inactivation of eNOS (13) .
In this study, we examine the relationship between CHIP and sGC and the role of CHIP in the ubiquitination and degradation of sGC. We show that CHIP forms a complex with sGC, ubiquitinates sGC in vitro and in intact cells and promotes degradation of sGC. Our data suggest that CHIP plays an important role in regulating sGC function.
H-00579-2007-R2
adenovirus containing wild-type or mutant CHIP gene (produced at the UNC Gene Therapy Vector Core Lab).
SDS-PAGE, Western blotting, and Immunoprecipitation
Cells grown on 6-well-plates were harvested 24-48 hours after transfection, washed 3 times with ice-cold PBS, and lysed with RIPA buffer (50mM Tris-HCl, pH 7.4, 1% IGEPAL CA-630, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM EDTA) supplemented with protease inhibitor cocktail (Calbiochem). Cell lysates were clarified by centrifugation at 14,000 rpm for 15 min at 4 o C, and protein concentration was determined with the BCA protein assay kit (Pierce). In some experiments, proteins in the pellet were recovered by boiling in SDS loading buffer. Proteins were resolved by SDS/PAGE, transferred to nitrocellulose membrane (Bio-Rad), and probed with appropriate antibodies. Immunoreactive bands were visualized with the chemiluminescence reagent, Immobulon (Millipore). Immunoprecipitation was done after pre-clearing the cell lysates (300μg) with mouse or rabbit IgG (Santa Cruz) and Protein A/G agarose beads (20 μl)for 1 hr at 4 o C, then appropriate antibodies (1μg) were added into the supernatant and samples were incubated overnight at 4 o C. Fifty μl Protein A/G agarose beads were added into the samples then rotated for 1 hr. Immunoprecipitated proteins bound to the agarose beads were transferred to spin filters (Microfilter, CA) and washed 4 times using RIPA buffer. Proteins were eluted from the beads by incubating with SDS sample buffer at room temperature, and analyzed by Western
Blotting. Optical densities of bands were estimated with ImageJ.
Pulse-chase analysis with cyclcoheximide
Cos-7 cells were transiently transfected with various expression plasmids, as described above. 24 hours after transfection, cycloheximide (CHX; 50μg/ml) was added and cells were incubated for various times. Cell lysates were then subjected to SDS-PAGE and immunoblotting analysis with antibodies to myc or β-actin.
Expression and purification of GST-sGCα1 and GST-sGCβ 1
Rat sGC α1 and β1 cDNA were sub-cloned into the GST fusion protein cloning vector pGEX-4T-1. Fusion GST-sGCα1 and GST-sGCβ1 proteins were expressed in E.Coli and purified by affinity binding to glutathione-Sepharose beads as previously described (25) .
Immunofluorescence
Indirect immunofluorescence was performed as described previously (1 were examined at 0.36μm intervals. 
In vitro ubiquitination assays
Statistical analysis
Data are expressed at mean ± SEM. All statistical tests were performed using ANOVA, P < 0.05 was accepted as statistically significant.
RESULTS
CHIP decreases the stability of sGC in Cos-7 cells
Using cycloheximide pulse-chase experiments, we investigated whether CHIP interferes with sGC stability. In the absence of CHIP, the half-life of over-expressed sGC α 1 and sGC β1was about 7 hours, whereas, in the presence of CHIP, the turnover of both sGC α 1 and sGC β1
increased and its half-life was reduced to about 3 hours (Fig.1 ). This data indicates that CHIP significantly reduces sGC protein levels.
CHIP promotes the proteasomal degradation of sGC subunits in Cos-7 cells
Since CHIP is a U-box ubiquitin E3 ligase responsible for the degradation of other hsp90 client proteins, we used transient transfection methods to investigate whether CHIP decreases sGC stability by enhancing its ubiquitination and proteasomal degradation. Cos-7 cells were transiently transfected with Myc-tagged CHIP and sGCα 1 subunit for 24 hours, and the soluble fraction of the cell lysates was analyzed by Western blotting. As shown in Figure 2A , transfection of Cos-7 cells with increasing amounts of wild type CHIP cDNA decreased the amount of expressed sGCα 1 , whereas hsp90, hsp70 and β-actin levels remained unaffected.
When the selective proteasome inhibitor, MG132 (5μM), was added to the cells for an additional 24 hours after transfection, sGCα 1 degradation by CHIP was almost abolished ( Figure 2B ); at the same time, increased total cell protein ubiquitination was observed. Results similar to sGCα 1 were obtained in Cos-7 cells co-transfected with Flag-tagged sGCβ1 subunit and CHIP (data not shown). These results suggest that CHIP enhances sGC degradation through the ubiquitinproteasome pathway. Since sGC functions as a heterodimer and single sGC subunits may be prone to degradation (16), we carried experiments to confirm that CHIP acts similarly on the intact sGC heterodimer, in Cos-7 cells co-transfected with both sGC subunits and CHIP. As shown in Figure 2C , both sGCα 1 and sGCβ 1 subunit expression decreases by wild type CHIP, suggesting that intact sGC is similarly affected by CHIP.
Both the TPR and U-Box domains are essential for CHIP-mediated sGC degradation
The E3 ligase CHIP has an amino-terminal TPR domain, which binds to hsp90/hsp70, and a Cterminal U-box domain, which is responsible the ubiquitin ligase activities (27). To test whether both domains were required for sGC subunit degradation, we used two mutant CHIP constructs:
CHIP (K30A), a TPR domain mutant, which does not bind hsp90 or hsp70, and CHIP (H260Q), a U-box domain mutant, which lacks protein ubiquitination abilities (11). Both the TPR and Ubox domain CHIP mutants decreased sGC subunits expression to a much lesser extend than wildtype CHIP ( Figure 2C ). These data suggest that both chaperone binding and ubiquitin ligase activities are necessary for CHIP-mediated sGC degradation. Although both mutants exhibited less sGC degradation than the wild-type CHIP, we observed less amount of sGC protein with the H260Q mutant compared to the K30A mutant in the supernatant fraction of cell lysates. When we probed the pellet fraction, it became evident that, in the presence of the H260Q mutant CHIP, sGC subunit expression remained unchanged compared to non-infected cells, however both sGC subunits were relocated to the detergent insoluble pellet fraction, along with the H260Q CHIP mutant ( Figure 2C ). Thus, the U-box mutant CHIP, H260Q, functions like a dominant-negative E3 ligase, which lacks ubiquitin ligase activity. Instead of stimulating the ubiquitin-proteasome pathway, it causes aggregation of misfolded proteins in the detergent insoluble pellet fraction.
This appears similar to what has been described for nucleophosmin-anaplastic lymphoma kinase (5) .
CHIP associates with sGC
To examine whether CHIP associates with sGC in intact cells, Cos-7 cells were co-transfected with Myc-tagged sGCα 1 and wild-type CHIP; non-transfected cells served as controls. 24 hours later, cells were fixed, stained with anti-CHIP primary and secondary (Cy2, green), anti-Myc primary and secondary antibodies (Cy3, red) and Hoechest 33258 dye to visualize the nuclei (blue) and examined under a confocal microscope. As shown in Figure 3A , there was strong association of sGCα 1 and CHIP in the cytoplasmic region (1.09μm section in a 0-2.9μm z-axis)
of Cos-7 cells (yellow hue). Cells that were not infected with either sGCα 1 (white arrows) or both sGCα 1 and CHIP (yellow arrows) did not exhibit yellow color in the merge mode. This observation was further verified with immunoprecipitation experiments. sGCα 1 was immunoprecipitated from Cos-7 cells co-transfected with sGCα 1 with or without wild-type CHIP;
immunoprecipitates were then immunoblotted with anti-CHIP antibody. As shown in Figure 3B , strong expression of CHIP was observed in immunocomplexes pulled down by anti-sGCα 1
antibody. In agreement with previous reports, there were also associations between sGC, hsp90 and hsp70 (2, 25) . To increase the stability of sGC protein and immunoprecipitation efficiency, in additional experiments we included the proteasome inhibitor, MG132 (5μM), for 6 hours before cell harvesting. Co-expression of sGCα 1 
CHIP enhances sGC ubiquitination in vitro
For a protein to be recognized and then degraded by the proteasome system, it first needs to be ubiquitinated. To investigate whether CHIP directly ubiquitinates sGC, we performed an in vitro ubiquitination assay using purified proteins: purified GST-sGCα 1 , His-tagged wild type or U-box mutant CHIP, human recombinant E1, E2 (UbcH5a) and ubiquitin. As seen in Figure 4 , addition of wild-type CHIP to the assay mixture caused the ubiquitination of sGCα 1 (reflected in a high molecular weight smear); re-probing of the same blot with anti-ubiquitin antibody confirmed the enhanced ubiquitination by the wild-type CHIP. These data suggest that CHIP can serve as an E3
ubiquitin ligase for sGC. Conversely, the U-box mutant CHIP lacked E3 ligase activity and did not ubiquitinate sGCα 1 . Our results indicated that CHIP directly ubiquitinates sGC in vitro and promotes its degradation by the proteasome system. Similar results were obtained using purified GST-sGCβ 1 protein (data not shown).
CHIP induces sGC ubiquitination in Cos-7 cells
To investigate whether CHIP induces sGC ubiquitination in intact cells, we tested if cotransfection of CHIP with both sGC subunits affects the ubiquitination of sGC in Cos-7 cells.
Cell lysates were immunoprecipitated using either anti-sGCα 1 or anti-sGCβ 1 antibody and immunoblotted for sGCα 1 sGCβ 1 and HA-tagged ubiquitin. As shown in Figure 5 Figure 6 , the proteasome inhibitor increased ubiquitination and expression of both sGC subunits.
Overexpression of CHIP enhances geldanamycin-induced sGCα 1 degradation
The hsp90 
Ad-CHIP promotes endogenous sGC degradation in vascular smooth muscle cells
To investigate whether CHIP reduces the stability of endogenous sGC, we used early passage (2-4) rat aortic smooth muscle cells (RASMC), harvested in our lab, because they exhibit high endogenous expression of both sGC subunits. Expression of wild-type or mutant CHIP was achieved by adenovirus-CHIP infection into RASMC for 24 hours. Cell lysates were collected and analyzed by western blotting. Over-expression of wild type CHIP degraded endogenous sGCα1 and sGCβ1 ( Figure 8A ). Compared to non-infected cells, low concentration of wild type Ad-CHIP caused approximately 40% decrease in sGCα 1 and sGCβ 1 expression, while the higher concentration of wild-type CHIP slightly further decreased sGCα 1 and sGCβ 1 expression ( Figure   8B ). Conversely, the chaperone interaction deficient, TPR domain mutant K30A CHIP failed to reduce sGC expression, indicating that CHIP-induced sGC degradation is chaperone dependent.
Furthermore, in agreement with previous reports (8), wild-type CHIP, but not the TPR-mutant CHIP dose-dependently increased hsp70 expression. Taken together, these results suggest that increased expression of hsp70 plays a role in the degradation of endogenous sGC by CHIP in RASMC.
CHIP attenuates the vasorelaxant effects of NO
Nitric oxide relaxes blood vessels by stimulating sGC to produce cGMP. We tested the hypothesis that because CHIP promotes sGC degradation, it would also attenuate NO-mediated vascular relaxation. Rat aortic rings exposed to vehicle exhibited a robust relaxation to the NO donor, spermine nonoate ( Figure 9A ). Conversely, vessels exposed to ad-CHIP exhibited a significant right-ward shift in the concentration-response curve and a significant reduction in the magnitude of maximal relaxation to spermine nonoate. Vessels exposed to the CHIP mutant K30A, that lacks the ability to bind to hsp90/hsp70, responded similar to vehicle-exposed, control rings. Western blot analysis of vessel ring lysates confirmed that Ad-CHIP, but not Ad-K30 reduced expression of both sGCα 1 and sGCβ 1.
DISCUSSION
Post-translational protein-protein interaction is an important regulatory mechanism for sGC functions. We have previously demonstrated that eNOS and sGC are associated with hsp90 in multimeric complexes (25) . The existence of hsp90-eNOS-sGC complex in endothelial cells would increase the efficacy of NO as the proximity of eNOS to sGC would attenuate inactivation of NO by superoxide anions and therefore improve the responsiveness of sGC to NO (25) . Later Balashova et al (2) demonstrated that hsp70 is also a sGC associated protein, which could increase the cGMP-forming ability of the enzyme. Inhibition of hsp90 by geldanamycin leads to proteasomal degradation of sGC subunits (18) further verifying that sGC is an hsp90 client protein.
In the present study, we report on another sGC interacting molecule, CHIP, which downregulates exogenous and endogenous sGC through the ubiquitin proteasome pathway (UPP).
Removal of misfolded or damaged proteins via the UPP is an important mechanism in terms of protein quality control. For a protein to be recognized by the 26S proteasome, it must be ubiquitinated by a multiple enzyme cascade involving at least three distinct types of enzymes: a ubiquitin-activating enzyme (E1), a ubiquitin conjugating enzyme (E2) and a ubiquitin ligase (E3). E3 enzymes catalyze the final step for substrate recognition in UPP and add ubiquitin chains to target proteins. Hundreds of E3 ligases have been described reflecting the diversity and specificity of proteins that they interact with (26). As a U-box E3 ligase, CHIP was originally identified as a tetratricopeptide repeats containing protein that interact with hsc/hsp70 (3). CHIP binds directly to the molecular chaperones hsp90 or hsp70 via their TPR domain and, through its C-terminal E3 ligase activity, it causes degradation of multiple target proteins, such as glucocorticoid hormone receptor (GR)(6), cystic fibrosis transmembrance conductance regulator (CFTR)(15) and ErbB2 (27) . Our current data demonstrate that sGC is a new CHIP target protein.
Thus the hsp90/hsp70 chaperones not only enhance sGC activity, but in some occasions also help decrease sGC protein levels through the UPP. It appears that these opposing actions of chaperones are under elegant regulation, but conditions that favor enhancing or down-regulating sGC activities need further examination. As an hsp90/hsp70 interacting protein, CHIP might play a role in determining the fate of sGC. Under physiological conditions, intracellular concentrations of CHIP are low relative to those of folding co-chaperones, such as hsp40 and hsp90, so that conditions that favor folding rather than degradation prevail. However, 2-4 fold elevation of CHIP is sufficient to drive CFTR and GR to the UPP for degradation (6, 15 immunoprecipitates from naïve cells (not transfected with CHIP), it is unclear if hsp90 and hsp70 expression are different ( Figure 3B ), but when CHIP was co-transfected or cells were treated with CHIP and geldanamycin, hsp70 was preferentially over-expressed and was the dominant co-precipitated chaperone, suggesting that CHIP and geldanamycin increase the amount of hsp70 associated with sGC. This is similar to what was reported for ErbB2 (27).
However, in contrast to ErbB2, we did not observe a reduction in the amount of co-precipitated hsp90 in either condition; instead, geldanamycin and overexpression of CHIP increased hsp90 association with sGC. Therefore, a better understanding of the role of each chaperone is still needed.
The hsp90 inhibitor, geldanamycin, replaces the nucleotide in the hsp90 binding "pocket"
and forces chaperone complexes into an ADP-like bound conformational state, which favors client protein degradation (22) . Interestingly, we found that CHIP and geldanamycin exert similar negative effects on sGC stability (Figure 7) , suggesting a cooperative action between the two molecules, as previously reported for ErbB2 and nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) (5, 27) . In addition, when Cos-7 cells were exposed to geldanamycin, druginduced degradation of exogenous sGC was enhanced in the presence of wild-type CHIP.
Our intact cell data revealed that both TPR and U-box domains are necessary for the CHIP-mediated degradation of sGC, suggesting that this process is chaperone-dependent.
However molecular chaperones such as hsp90 or hsp70 were not required for CHIP-mediated in vitro sGC ubiquitination (hsp90 or hsp70 protein levels were not detectable in purified GST-sGC and His-CHIP preparations; data not shown). Since the in vitro reactions contained both E1 and E2, it may be that assembly of activating and conjugating enzymes is a primary role of these chaperones. Indeed, the following evidence support the hypothesis that chaperone function is necessary for CHIP activity in sGC ubiquitination and degradation: 1) the TPR mutant CHIP degrades sGC substantially less than the wild type CHIP; 2) in in vitro conditions, both sGC and CHIP are in excess concentrations, hence precluding the need for hsp90/hsp70 to recruit CHIP for sGC ubiquitination. Hatakeyama (10) and Timsit (24) described similar observations in the case of Tau and Epsin proteins. However, it is still possible that CHIP not only associates with sGC indirectly via chaperones, but that it also binds to sGC directly, as in the case of the androgen receptors (12).
Our ex-vivo, vascular findings support the cell data. CHIP-, but no K30A-exposed vessels exhibited a severely attenuated response to NO and reduced sGC expression, suggesting that CHIP-induced degradation of sGC has important physiological consequences and that it requires association of CHIP with hsp90. These findings also agree with our previous work showing that hsp90 inhibitors reduce vascular relaxation in response to spermine nonoate and other NO donors (28).
In summary, our results demonstrate for the first time that CHIP is a novel sGC interacting protein that decreases the stability of both heterologous sGC subunits, ubiquitinates sGCα 1 and sGCβ 1 in intact cells and in vitro and prepares the sGC heterodimer for proteasome degradation.
We also show that the hsp90 inhibitor, geldanamycin, degrades sGCα 1 Cell lysates were collected and analyzed by Western blotting using anti-Myc, anti-Flag and antiactin antibodies (representative blots from four independent experiments). 
